Michael Moran
2021
In 2021, Michael Moran earned a total compensation of $1.9M as Chief Commercial Officer at Eagle Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $418,540 |
|---|---|
| Salary | $424,296 |
| Stock Awards | $987,362 |
| Other | $27,735 |
| Total | $1,857,933 |
Moran received $987.4K in stock awards, accounting for 53% of the total pay in 2021.
Moran also received $418.5K in non-equity incentive plan, $424.3K in salary and $27.7K in other compensation.
Rankings
In 2021, Michael Moran's compensation ranked 6,332nd out of 12,415 executives tracked by ExecPay. In other words, Moran earned more than 49.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,332 out of 12,415 | 49th |
Division Manufacturing | 2,694 out of 5,501 | 51st |
Major group Chemicals And Allied Products | 1,182 out of 2,371 | 50th |
Industry group Drugs | 1,052 out of 2,092 | 50th |
Industry Pharmaceutical Preparations | 762 out of 1,542 | 51st |
Pay ratio
| Michael Moran's Pay | $1,857,933 |
|---|---|
| Median Employee's Pay | $246,233 |
| Pay Ratio | 8to 1 |
In 2021, the annual total compensation of Michael Moran was $1,857,933.
The annual total compensation of the median employee at Eagle Pharmaceuticals was $246,233.
The ratio of Michael Moran's pay to the pay of median employee was therefore 8 to one.
Source: SEC filing on June 15, 2022.
Moran's colleagues
We found four more compensation records of executives who worked with Michael Moran at Eagle Pharmaceuticals in 2021.